(NP (-LRB- -LCB-) (NP (NN Mechanism)) (PP (IN of) (NP (NP (NN action)) (PP (IN of) (NP (NN steroid) (NNS hormones) (. .) (LS I) (. .) (NNS Estrogens))))) (-RRB- -RCB-))
(S (S (NP-SBJ (DT The) (NN steroid) (NN hormone)) (VP (VBP are) (NP-PRD (ADJP (RB very) (JJ versatile)) (NNS molecules))) (: :)) (S (SBAR-ADV (IN although) (S (NP-SBJ (PRP they)) (VP (VBP are) (ADJP-PRD (JJ related)) (PP (IN among) (NP (PRP them))) (PP (IN by) (NP-PRD (PRP$ their) (JJ chemical) (NN structure)))))) (, ,) (NP-SBJ (PRP they)) (VP (VBP have) (NP (NP (ADJP (RB very) (JJ diverse)) (NNS functions)) (CC and) (PP (VBG including) (NP (JJ antagonic))))) (. .)))
(S (NP-SBJ-27 (PRP$ Their) (NN action) (NN mechanism)) (VP (VBZ is) (RB not) (ADVP (RB completely)) (VP (VBN cleared) (NP (-NONE- *-27)))) (. .))
(S (NP-SBJ (DT The) (NNS estrogens)) (VP (VBP participate) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (QP (RB practically) (PDT all)) (DT the) (ADJP-COOD (ADJP (JJ reproductive)) (CC and) (ADJP (JJ sexual))) (NNS events)) (PP (IN of) (NP (DT the) (NN female))))))) (, ,) (SBAR-ADV (IN although) (S-COOD (S (NP-SBJ-28 (NP (DT the) (JJ intracellular) (NNS actions)) (SBAR (WHPP-29 (IN by) (WHNP (WDT which))) (S (NP-SBJ (PRP they)) (VP (VBP take) (NP (NN place)) (PP (-NONE- *T*-29)))))) (VP (VBP are) (RB not) (ADVP (RB well)) (VP (VBN known) (NP (-NONE- *-28))))) (CC and) (S (NP-SBJ (DT the) (JJ proposed) (NNS models)) (VP (VBP do) (RB not) (ADVP (RB adequately)) (VP (VB satisfy) (NP (DT the) (NNS questions)))))))) (. .))
(S (ADVP-TMP (RB Currently)) (NP-SBJ (PRP it)) (VP (VBZ is) (VP (VBN accepted) (NP (NP (DT the) (NN existence)) (PP (IN of) (NP (DT a) (ADJP-COOD (ADJP (JJ cytoplasmic)) (CC (or and)) (ADJP (JJ nuclear))) (NN receptor)))) (, ,) (PP (IN without) (S (NP-SBJ (-NONE- *)) (VP (VBG explaining) (ADVP (RB satisfactorily)) (SBAR (WHADVP-100 (WRB how)) (S (NP-SBJ (DT the) (NNS hormones)) (VP (VBN come) (PP (TO to) (NP (DT the) (NN nucleus))) (ADVP (-NONE- *T*-100)))))))))) (. .))
(S (NP-SBJ (NP (DT The) (JJ endocrine) (NNS events)) (SBAR (WHNP-30 (WDT that)) (S (NP-SBJ-31 (-NONE- *T*-30)) (VP (VBP are) (ADVP-TMP (ADVP (RB rapidly)) (PRN (-NONE- *ICH*-101))) (VP (VBN expressed) (NP (-NONE- *-31)) (PRN-101 (-LRB- -LRB-) (NP-TMP (NNS seconds)) (-RRB- -RRB-))))))) (VP (VBP are) (PP-PRD (JJ due) (TO to) (NP (NP (DT a) (JJ possible) (NN interaction)) (PP (IN with) (NP (JJ cellular) (NN membrane)))))) (. .))
(S (NP-SBJ (NP (DT The) (NN purpose)) (PP (IN of) (NP (DT this) (NN review)))) (VP (VBZ is) (S-PRD (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VP-COOD (VP (VB analyze) (NP (-NONE- *RNR*-32))) (CC and) (VP (VB concilliate) (NP (-NONE- *RNR*-32)))) (NP-32 (NP (DT the) (VBN reported) (NNS data)) (PP (IN on) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NP (NN action)) (PP (IN of) (NP (NNS estrogens)))))))))))) (. .))
